wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q31033615-F41B75C0-0F69-4C0E-BD62-279299FF1286
Q31033615-F41B75C0-0F69-4C0E-BD62-279299FF1286
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31033615-F41B75C0-0F69-4C0E-BD62-279299FF1286
The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature.
P2860
Q31033615-F41B75C0-0F69-4C0E-BD62-279299FF1286
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31033615-F41B75C0-0F69-4C0E-BD62-279299FF1286
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36aa07854b6df110d9d22c38c96f4eef908c2e52
P2860
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia